| Assay ID | Title | Year | Journal | Article |
|---|
| AID1650591 | Antiproliferative activity against human HT1080 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay | 2020 | Bioorganic & medicinal chemistry, 01-15, Volume: 28, Issue:2
| Identification of vibsanin A analog as a novel HSP90 inhibitor. |
| AID1650592 | Antiproliferative activity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay | 2020 | Bioorganic & medicinal chemistry, 01-15, Volume: 28, Issue:2
| Identification of vibsanin A analog as a novel HSP90 inhibitor. |
| AID1650601 | Induction of vacuole formation in human HT1080 cells at 10 uM incubated for 24 hrs | 2020 | Bioorganic & medicinal chemistry, 01-15, Volume: 28, Issue:2
| Identification of vibsanin A analog as a novel HSP90 inhibitor. |
| AID1650599 | Antiproliferative activity against human PC3 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay | 2020 | Bioorganic & medicinal chemistry, 01-15, Volume: 28, Issue:2
| Identification of vibsanin A analog as a novel HSP90 inhibitor. |
| AID1650597 | Antiproliferative activity against human ES2 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay | 2020 | Bioorganic & medicinal chemistry, 01-15, Volume: 28, Issue:2
| Identification of vibsanin A analog as a novel HSP90 inhibitor. |
| AID1650596 | Antiproliferative activity against human SK-MEL-28 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay | 2020 | Bioorganic & medicinal chemistry, 01-15, Volume: 28, Issue:2
| Identification of vibsanin A analog as a novel HSP90 inhibitor. |
| AID1650598 | Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay | 2020 | Bioorganic & medicinal chemistry, 01-15, Volume: 28, Issue:2
| Identification of vibsanin A analog as a novel HSP90 inhibitor. |
| AID1650594 | Antiproliferative activity against human A431 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay | 2020 | Bioorganic & medicinal chemistry, 01-15, Volume: 28, Issue:2
| Identification of vibsanin A analog as a novel HSP90 inhibitor. |
| AID1650602 | Effect on Akt level in human HT1080 cells assessed as Akt level at 10 uM incubated for 24 hrs by immunoblot assay (Rvb = 1 No_unit) | 2020 | Bioorganic & medicinal chemistry, 01-15, Volume: 28, Issue:2
| Identification of vibsanin A analog as a novel HSP90 inhibitor. |
| AID1650600 | Antiproliferative activity against human NEC8 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay | 2020 | Bioorganic & medicinal chemistry, 01-15, Volume: 28, Issue:2
| Identification of vibsanin A analog as a novel HSP90 inhibitor. |
| AID1650593 | Antiproliferative activity against human PANC1 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay | 2020 | Bioorganic & medicinal chemistry, 01-15, Volume: 28, Issue:2
| Identification of vibsanin A analog as a novel HSP90 inhibitor. |
| AID1650595 | Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay | 2020 | Bioorganic & medicinal chemistry, 01-15, Volume: 28, Issue:2
| Identification of vibsanin A analog as a novel HSP90 inhibitor. |
| AID1650603 | Inhibition of Akt signaling pathway in human HT1080 cells assessed as fold change in phosphorylated Akt level at 10 uM incubated for 24 hrs by immunoblot assay (Rvb = 1 No_unit) | 2020 | Bioorganic & medicinal chemistry, 01-15, Volume: 28, Issue:2
| Identification of vibsanin A analog as a novel HSP90 inhibitor. |
| AID1650604 | Inhibition of Akt signaling pathway in human HT1080 cells assessed as fold change in phosphorylated 70S6K level at 10 uM incubated for 24 hrs by immunoblot assay (Rvb = 1 No_unit) | 2020 | Bioorganic & medicinal chemistry, 01-15, Volume: 28, Issue:2
| Identification of vibsanin A analog as a novel HSP90 inhibitor. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |